[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456579":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":35,"centralContacts":39,"locations":45,"responsibleParty":66,"collaborators":69,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":29,"eligibilityCriteria":80,"healthyVolunteers":77,"sex":81,"minAge":82,"maxAge":34,"enrollmentInfo":83,"targetDuration":34,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":100,"overallStatus":48,"whyStopped":34,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"QUALITATIVE ASSESSMENT","EXPERIMENTAL","This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review.\n\nIt is expected that about 20 people will take part in this part of the research study.\n\nIn the larger part of the study that will happen after this part of the study, it is expected 1000 people will participate.",[13],"Behavioral: Video Education",{"label":15,"type":10,"description":16,"interventionNames":17},"RCT-VERDI","A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling",[13],{"label":19,"type":10,"description":16,"interventionNames":20},"RCT-Genetic Counseling",[21],"Behavioral: Genetic Counseling",[23,30],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"BEHAVIORAL","Video Education","Investigator-developed, professionally animated and produced 8-minute video (Video Education) summarizing the core educational components of a genetic counseling visit",[9,15],[29],"VERDI",{"type":24,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Genetic Counseling","Standard genetic counseling",[19],null,[36],{"name":37,"affiliation":5,"role":38},"Huma Q. Rana, MD., MPH","PRINCIPAL_INVESTIGATOR",[40],{"name":41,"role":42,"phone":43,"phoneExt":34,"email":44},"Huma Q. Rana, MD. MPH","CONTACT","617) 632-6292","humaQ_rana@dfci.harvard.edu",[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Dana Farber Cancer Institute","RECRUITING","Boston","Massachusetts","02115","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-71.05977,42.35843,{"lat":58,"lon":57},[61,65],{"name":62,"role":42,"phone":63,"phoneExt":34,"email":64},"Huma Q Rana, MD","617-632-6292","HumaQ_Rana@DFCI.HARVARD.EDU",{"name":62,"role":38,"phone":34,"phoneExt":34,"email":34},{"type":38,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"Huma Rana, MD","Principal Investigator",[70,73],{"name":71,"class":72},"National Cancer Institute (NCI)","NIH",{"name":74,"class":72},"National Human Genome Research Institute (NHGRI)","100456579","video-education-with-result-dependent-disclosure-100456579",false,"NCT05225428","Video Education With Result Dependent dIsclosure","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma\n* Ability to understand spoken or written English or Spanish in a healthcare context\n* Ability to understand and the willingness to sign a written informed consent document\n* Black or Latinx (qualitative assessment study only)\n\nExclusion Criteria:\n\n* Prior cancer genetic testing\n* Prior germline genetic testing\n* Active hematologic malignancy (e.g. chronic lymphocytic leukemia)\n* Currently pregnant\n* Currently incarcerated","ALL","18 Years",{"count":84,"type":85},1020,"ESTIMATED","INTERVENTIONAL",[88],"NA","The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.",[91,92,93,94,95,96,97,98,99],"Genetic Testing","Breast Cancer","Ovarian Cancer","Pancreatic Cancer","Prostate Cancer","Colorectal Cancer","Renal Cancer","Melanoma","Sarcoma",[91,92,93,94,95,96,97,98,99],"2026-05-20",{"date":103,"type":104},"2026-05-22","ACTUAL",{"date":106,"type":104},"2022-08-04",{"date":108,"type":85},"2026-10-01",{"name":5,"class":6},1]